Elanco

Read more
Jeffrey N. Simmons's photo - President & CEO of Elanco

President & CEO

Jeffrey N. Simmons

CEO Approval Rating

100/100

Founded:

1954

Status:

ELANCO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Jeffrey N. Simmons

President & CEO

- -
5,590
$1.5B
$3.9B
View Profile
1

Kristin Peck

CEO

96/100
10,000
$5B
$7B
View Profile
2

Hubertus von Baumbach

Chairman

77/100
51,944
- -
$28.6B
View Profile
3

Richard R. DeLuca

President

81/100
10,000
- -
$4.8B
View Profile
4

Geraldine Matchett

Co-CEO

78/100
23,127
$3.8B
$10B
View Profile
5

J.K. Symancyk

President & CEO

88/100
55,000
- -
$7B
View Profile
6

Marc Prikazsky

Chairman & CEO

91/100
3,608
- -
$1.2B
View Profile
7

Dame Emma Walmsley

CEO

74/100
94,066
- -
$45.2B
View Profile
8

Jack Bendheim

President & CEO

83/100
46
- -
$15M
View Profile
9

Vasant Narasimhan

CEO

88/100
110,000
- -
$50.4B
View Profile
10

Werner Baumann

Chairman & CEO

51/100
99,329
- -
$51.1B
View Profile

Missing a competitor? Contribute!

Zoetis is the top competitor of Elanco. Zoetis is a Public company that was founded in Parsippany, New Jersey in 1952. Like Elanco, Zoetis also operates in the Pharmaceuticals sector. Zoetis has 5,710 more employees vs. Elanco.

Boehringer Ingelheim is seen as one of Elanco's biggest rivals. Boehringer Ingelheim was founded in Ingelheim am Rhein, Rhineland-Palatinate} in 1885. Like Elanco, Boehringer Ingelheim also competes in the Pharmaceuticals space. Compared to Elanco, Boehringer Ingelheim generates $24.7B more revenue.

Merck Animal Health is perceived as one of Elanco's biggest rivals. Merck Animal Health was founded in 1940, and is headquartered in Madison, New Jersey. Like Elanco, Merck Animal Health also operates in the Pharmaceuticals space. Merck Animal Health generates $942.7M more revenue vs. Elanco.

Elanco Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$3.9B

Elanco's revenue is the ranked 16th among it's top 10 competitors. The top 10 competitors average 27.5B. Over the last four quarters, Elanco's revenue has grown by 111.8%. Specifically, in Q1 2021's revenue was $1.2B; in Q4 2020, it was $1.1B; in Q3 2020, it was $889.6M; in Q2 2020, Elanco's revenue was $586.3M.

Elanco Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Kindred Biosciences, Inc.

Jun 2021

Source »
$440M
KindredBio is a California-based veterinary biopharmaceutical company that develops and commercializes protein pet therapeutics for dogs, cats and horses.

-

Animal Health Business, Bayer AG

Aug 2019

Source »
$7.6B
-
Prevtec Microbia, Inc.

Aug 2019

Source »
$59.7M
Prevtec Microbia is a biotechnology firm that develops and commercializes antibiotics and vaccines for animals.
Aratana Therapeutics, Inc.

Apr 2019

Source »
$245M
Aratana Therapeutics develops and commercializes small molecule therapeutics to treat osteoarthritis in pet animals.

-

U.S. Rabies Vaccine Business, Boheringer Inghelheim

Oct 2016

Source »
$885M
-

These are all the companies that Elanco has acquired. Elanco has acquired 6 companies and its latest acquisition was Kindred Biosciences, Inc. in Jun 2021. KindredBio is a California-based veterinary biopharmaceutical company that develops and commercializes protein pet therapeutics for dogs, cats and horses.

Elanco Funding History

Since Elanco was founded in 1954, it has participated in 1 round of funding. In total Elanco has raised $1.5B. Elanco's funding round was on Sep 2018 for a total of $1.5B

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Sep 2018
$1.5B
-

Since Elanco was founded in 1954, it has participated in 1 round of funding. In total Elanco has raised $1.5B. Elanco's funding round was on Sep 2018 for a total of $1.5B

Elanco Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

-
Apr 18, 2021
Corporate Round
-
Resilient Biotics is a pharmaceutical firm that researches and develops microbiome-based live biotherapeutics for animal health.
$7.1M
Dec 01, 2020
Series A
-
AgTech Accelerator identifies, forms, finances and manages the emerging agriculture companies for commercialization.
$8.5M
Oct 31, 2016
Equity
-

These are all the companies that Elanco has invested in. Elanco has invested 3 companies and its latest investment was Stonehaven in Apr 18,.

Elanco News

July 17, 2021ChinaPulse

Point72 Hong Kong Ltd Makes New $412,000 Investment in Elanco Animal Health Incorporated (NYSE:ELAN) WKRB News

Point72 Hong Kong Ltd bought a new stake in shares of Elanco Animal Health Incorporated (NYSE:ELAN) d... See more »
July 12, 2021MarketScreener

Confirms Date and Conference Call for Second Quarter 2021 Financial Results Announcement

(marketscreener.com) Elanco Animal Health Incorporated will announce its second quarter 2021 financia... See more »
June 30, 2021MarketScreener

Foundation Announces Three-Year Partnership with the JBS Fund

(marketscreener.com) Post by: Jared Skok First external organization to contribute to RestaurAmazônia... See more »
June 17, 2021Pharmabiz

Elanco Animal Health to acquire Kindred Biosciences for $440 million

Elanco Animal Health Incorporated, a global leader in animal health, and Kindred Biosciences, Inc. an... See more »
June 17, 2021Markets Insider

Rowley Law PLLC is Investigating Proposed Acquisition of Kindred Biosciences, Inc.

NEW YORK, June 16, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law vio... See more »
June 16, 2021Inside Indiana Business

Elanco Acquires Pet Therapeutics Company

Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) says it has acquired California-based Kindred... See more »
June 16, 2021The Business Journals: San Francisco Business Times

Doggy drug developer digs up $440M acquisition deal

The company was one of the first biotech animal drug companies - developing drugs for dogs, cats and ... See more »

Elanco Press Releases

February 19, 2021Business Wire

Elanco to Participate in the Cowen 41st Annual Health Care Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in... See more »
January 27, 2021Business Wire

Elanco Confirms Date and Conference Call for Fourth Quarter 2020 Financial Results Announcement

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its f... See more »
January 11, 2021Business Wire

Elanco Begins Next Phase of Integration Post-Bayer Animal Health Acquisition; Executive Committee Member Sarena Lin to Depart

GREENFIELD, Ind.--(BUSINESS WIRE)--Today Elanco Animal Health Incorporated (NYSE: ELAN) announced tha... See more »
December 14, 2020Business Wire

Elanco Appoints New Independent Directors to the Board and Expands Innovation and Operational Oversight

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced tha... See more »
December 1, 2020StreetInsider

Elanco Announces Pricing of Public Offering of Common Stock by Selling Shareholder

GREENFIELD, Ind.--(BUSINESS WIRE)-- Elanco Animal Health Incorporated (NYSE: ELAN) today announced th... See more »
November 19, 2020Business Wire

Elanco to Participate in the 3rd Annual Evercore ISI Virtual HealthCONx Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in... See more »
October 29, 2020Business Wire

Elanco to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in... See more »

Elanco Videos

Social Media

Elanco Headquarters

2500 Innovation Way

Greenfield, Indiana46140

1-877-352-6261

Driving Directions »

Trending Companies

Elanco Summary

ABOUT

Overview

Elanco engages in developing products and services that enhance animal health, wellness and performance. Elanco was founded in 1954. Elanco's headquarters is located in Greenfield, Indiana, USA 46140. It has raised 1.5B in 1 round. The latest round wa...

CEO

Elanco's President & CEO, Jeffrey N. Simmons, currently has an approval rating of 100%. Elanco's primary competitors are Zoetis, Boehringer Ingelheim & Merck Animal Health.

Website

elanco.com

Frequently Asked Questions about Elanco

  1. When was Elanco founded?

    Elanco was founded in 1954
  2. Who is Elanco's CEO?

    Elanco's CEO is Jeffrey N. Simmons
  3. How much revenue does Elanco generate?

    Elanco generates $3.9B in revenue
  4. How much funding does Elanco have?

    Elanco has historically raised $1.5B in funding
  5. Where is Elanco's headquarters?

    Elanco's headquarters is in Greenfield Indiana, USA
  1. How many employees does Elanco have?

    Elanco has 5,590 employees
  2. What sector does Elanco operate in?

    Elanco is in Pharmaceuticals
  3. Who are Elanco's competitors?

    Elanco's top competitors are Zoetis, Boehringer Ingelheim, Merck Animal Health
  4. Who has Elanco invested in?

    Elanco's has invested in companies such as Stonehaven, Resilient Biotics, Agtech Accelerator